Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Mon, 30.09.2024
Noratis AG
Noratis AG publishes figures as of June 30, 2024
2nd creditors' meeting for the 2020/2025 bond on October 8, 2024
Eschborn, September 30, 2024 - Noratis AG (share: ISIN: DE000A2E4MK4 / WKN: A2E4MK), a leading portfolio developer of residential real estate in Germany, has closed the first half of 2024 in line with the preliminary figures published [ … ]
Mon, 30.09.2024
Syngenta Group
Syngenta Group
/ Key word(s): Miscellaneous
Syngenta Group adds Cutting-Edge Generative Artificial Intelligence (GenAI) to Cropwise 30.09.2024 / 08:00 CET/CEST
30 September 2024, Basel, Switzerland
Syngenta Group, a global leader in agricultural innovation, announced the launch of Cropwise AI at the World AgriTech Innovation [ … ]
Mon, 30.09.2024
123fahrschule SE
123fahrschule closes first half-year with positive EBITDA.
30.09.2024
Cologne, September 30, 2024 - 123fahrschule SE (ISIN: DE000A2P4HL9; ticker symbol: 123F, primary market Düsseldorf Stock Exchange), a digitally driven driving school chain in Germany with a focus on e-learning, reports a positive business performance in the first half of [ … ]
Mon, 30.09.2024
GoldenPeaks Capital Holding Ltd.
GoldenPeaks Capital Holding Ltd.
/ Key word(s): Partnership
GoldenPeaks Capital and CNBM strengthen their renewable energy partnership and commit to target a 1GW project pipeline annually in Europe.
30.09.2024 / 08:00 CET/CEST
GoldenPeaks Capital and CNBM strengthen their renewable energy partnership and commit to [ … ]
Mon, 30.09.2024
Formycon AG
Press Release // September 30, 2024
Formycon and Fresenius Kabi receive FDA approval for FYB202/ OtulfiTM (ustekinumab-aauz)
OtulfiTMreceived FDA approval for both subcutaneous and intravenous formulations, to treat the same conditions as Stelara®
Approval represents the third successful FDA approval for a Formycon biosimilar, two of them in [ … ]
Mon, 30.09.2024
Branicks Group AG
Frankfurt am Main, September 30, 2024
Press release of the Branicks Group AG
Branicks wins REWE as a further anchor tenant for the “Neustadt Centrum” in Halle
REWE grocery store on 5,400 sqm
Lease agreement runs for 15 years
Aiming for a high level of sustainability
Excellent sector network and proactive asset management service as the b [ … ]
Mon, 30.09.2024
Aperam S.A.
Aperam S.A.
/ Key word(s): Miscellaneous
Aperam update on Q3 2024 market & financial trends 30-Sep-2024 / 06:59 CET/CEST
Aperam update on Q3 2024 market & financial trends
Luxembourg, September 30, 2024 (07:00 CET) - In preparation of the upcoming quarterly results release scheduled for Friday, 8 November 202 [ … ]
Mon, 30.09.2024
Belimo Holding AG
Belimo Holding AG
/ Key word(s): Personnel
Sandra Pitt to become a Member of the Executive Committee of the Belimo Group
30.09.2024 / 06:00 CET/CEST
The Board of Directors of the BELIMO Holding AG has appointed Sandra Pitt (53) as a member of the Executive Committee with effect from January 1, 2025.
Sandra Pitt assu [ … ]
Mon, 30.09.2024
Kapsch TrafficCom AG
EQS-Media / 30.09.2024 / 03:15 CET/CEST
Award-winning GNSS tolling system covers 16,000 km of roads
System was awarded for design, implementation and positive impact
Vienna, Austria, September 30, 2024 – Kapsch TrafficCom is proud to announce that the Bulgarian "Nationwide Tolling & E-Vignette System" was awarded the prestigious Road Fina [ … ]
Fri, 27.09.2024
Nyxoah SA.
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Additional clinical data on patients suffering from Obstructive Sleep Apnea (OSA) demonstrate a clinically significant 71.0% median reduction in Apnea-Hypopnea index (AHI) while sleeping supine at 12 months compared with baseline.
82.0% of patie [ … ]